(Q44574975)

4 December 2017

Endothelial dysfunction in young patients with long-term rheumatoid arthritis and low disease activity (English)

1 reference

4 December 2017

1 reference

Sven Hänsel

1

1 reference

4 December 2017

Grit Lässig

series ordinal

2

1 reference

4 December 2017

Frank Pistrosch

series ordinal

3

1 reference

4 December 2017

Jens Passauer

series ordinal

4

1 reference

4 December 2017

1 September 2003

1 reference

4 December 2017

1 reference

4 December 2017

170

1 reference

4 December 2017

1

1 reference

4 December 2017

177-180

1 reference

The mortality of rheumatoid arthritis

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900281-8

Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: lessons for atherosclerotic disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900281-8

Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900281-8

Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900281-8

Measuring forearm blood flow and interpreting the responses to drugs and mediators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900281-8

Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900281-8

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900281-8

Acute systemic inflammation impairs endothelium-dependent dilatation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900281-8

Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900281-8

Proinflammatory mediators chronically downregulate the formation of the endothelium-derived hyperpolarizing factor in arteries via a nitric oxide/cyclic GMP-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900281-8

Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900281-8

Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900281-8

Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900281-8

Prognostic significance of endothelial dysfunction in hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900281-8

10.1016/S0021-9150(03)00281-8

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference